Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Milestone Pharmaceuticals Inc. - Common Shares (NQ:MIST)

1.560 +0.020 (+1.30%)
Streaming Delayed Price Updated: 10:32 AM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Milestone Pharmaceuticals Inc. - Common Shares

< Previous 1 2 3 Next >
Let's take a look at the stocks that are in motion in today's session.
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Which stocks are moving on Friday?
Stay up-to-date with the latest market trends in the middle of the day on Friday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
Milestone Pharmaceuticals: Q4 Earnings Insights
Via Benzinga
Why Milestone Pharmaceuticals (MIST) Stock Is Rising
Milestone Pharmaceuticals shares are trading higher by 19.4% Monday morning. The company announced plans to resubmit the NDA for etripamil to the FDA. 
Via Benzinga
Why Is Milestone Pharmaceuticals Stock Plunging On Friday?
FDA accepts Milestone's response on Cardamyst nasal spray, sets new PDUFA date; company raises $52.5 million to support potential PSVT treatment launch. 
Via Benzinga
Dow Dips Over 200 Points; Levi Strauss Posts Upbeat Earnings
Via Benzinga
Topics Stocks
There are notable gap-ups and gap-downs in today's session.
Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
Wondering what's happening in today's pre-market session?
The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Top movers analysis one hour before the close of the markets on 2025-03-28: top gainers and losers in today's session.
Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
Top movers in Friday's session
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements. 
Via Chartmill
Milestone Pharmaceuticals Stock Plunges 60% After FDA Declines To Approve Its Cardamyst Nasal Spray – But Retail’s Positive
The FDA said an inspection is required at a facility where the company performed release testing for the product to ensure it complies with Current Good Manufacturing Practices. 
Via Stocktwits
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Traders are paying attention to the gapping stocks in Friday's session.
Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session. 
Via Chartmill
Dow Tumbles Over 500 Points; Abacus Global Management Shares Spike Higher
Via Benzinga
Topics Stocks
Top movers in Friday's pre-market session
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
Why Is Milestone Pharmaceuticals Stock Plunging Today?
Milestone Pharmaceuticals' stock drops over 61% after receiving a Complete Response Letter from the FDA for its CARDAMYST NDA. 
Via Benzinga
Nasdaq Down 100 Points; Federal Reserve's Favorite Inflation Gauge Increases More Than Expected
Via Benzinga
Topics Economy
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
MIST Stock Earnings: Milestone Pharmaceuticals Beats EPS for Q2 2024
MIST stock results show that Milestone Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
MIST Stock Earnings: Milestone Pharmaceuticals Beats EPS for Q1 2024
MIST stock results show that Milestone Pharmaceuticals beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
MIST Stock Earnings: Milestone Pharmaceuticals Misses EPS for Q4 2023
MIST stock results show that Milestone Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Shares of Okta, Inc. (NASDAQ: OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and 
Via Benzinga
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning! 
Via InvestorPlace
Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS